Franklin Resources: Risky Pivot To Alternatives And Tokenization

Franklin Resources' aggressive focus on Alternative Assets has failed to deliver management fee margin expansion, raising ...

Picard Medical: FDA-Approved Artificial Heart, But Ramp-Up Remains Uncertain

PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...